http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3923974-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a5173a7d063a9f70ca7b5e86fc23863
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-10
filingDate 1974-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1975-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af576312dc233e4c60945d335e89668f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfa575e912c91ffa1dd1070e1477c136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8d00789f935fce799a0ba356673523f
publicationDate 1975-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3923974-A
titleOfInvention Solid fine crystalline paracetamol polymer complex composition
abstract One aspect of the invention is a method of preparing a composition which is suitable for direct tablet compression and which comprises crystals containing a mixture of paracetamol and a polymer, said method which comprises providing a hot aqueous solution containing paracetamol and from 1 to 15%, by weight on the weight of the paracetamol, of a polymer selected from homopolymers and copolymers of vinyl acetate and vinyl pyrrolidone, cooling said solution with gentle stirring and recovering said composition. Preferred compositions are obtained using the polymer in an amount from 2 to 6% by weight on the weight of the paracetamol and using as the polymer a copolymer of vinyl pyrrolidone and vinyl acetate in a weight ratio of from 70:30 to 50:50. The composition is preferably dried to a moisture level of from 0.4 to 1.4% by weight. Another aspect of the invention is the said composition of paracetamol and polymer, a preferred embodiment containing from 1.5 to 5% by weight of a copolymer of vinyl pyrrolidone and vinyl acetate in a weight ratio of from 70:30 to 50:50. Still another aspect of the invention is the tablet formed by direct tablet compression of said composition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5037658-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4600579-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010184861-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8951562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5198228-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4661521-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9700513-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3448522-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011089087-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8581134-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008056021-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4757090-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4684698-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3441308-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2557365-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265272-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8968788-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009135946-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011140298-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006157878-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008056021-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2456989-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8052999-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2456989-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5130140-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008111269-A1
priorityDate 1973-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2667473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3851032-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450108871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419129972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449481087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID270885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158576428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448950291

Total number of triples: 58.